Jeffrey S. Baggish - Concepedia

Author

Jeffrey S. Baggish

CSL (United States)

Also Known As

J S Baggish, J. Baggish, J.S. Baggish, Jeffrey Baggish, Jeffrey S Baggish, Jeffrey S. Baggish, Whitehead, William E

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

CSL (United States)Johns Hopkins University University of North Carolina at Chapel Hill California Medical Clinic for Headache

About

Jeffrey S. Baggish is an author at CSL (United States) specializing in medicine, immunotherapy, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	145
2	Health Sciences	1	1	14
3	Social Sciences	1	1	131
4	Behavioral Health	1	1	131
5	Immunology	1	1	14

Jeffrey S. Baggish

Publications

681

Citations

H-Index

Page 1

	Year	Citations
Efficacy and Safety of Acetaminophen in the Treatment of Migraine R.B. Lipton, Jeffrey S. Baggish, Walter F. Stewart, Archives of Internal Medicine	2000	140
Coping strategies and health care—seeking behavior in a US national sample of adults with symptoms suggestive of overactive bladder Judith A. Ricci, Jeffrey S. Baggish, Timothy Hunt, Clinical Therapeutics Behavioral MedicinePsychopathologyPsychiatryUs National SampleSocial Sciences	2001	131
IBS Patients Show Frequent Fluctuations Between Loose/Watery and Hard/Lumpy Stools: Implications for Treatment Olafur S. Palsson, Jeffrey S. Baggish, Michael J. Turner, The American Journal of Gastroenterology	2011	95
Aspirin Is Efficacious for the Treatment of Acute Migraine Richard B. Lipton, Jerome Goldstein, Jeffrey S. Baggish, Headache The Journal of Head and Face Pain	2005	87
Acetaminophen, Aspirin, and Caffeine Versus Sumatriptan Succinate in the Early Treatment of Migraine: Results From the ASSET trial Jerome Goldstein, Stephen D. Silberstein, Joel R. Saper, Headache The Journal of Head and Face Pain	2005	80
Retrospective analysis of transient elevations in alanine aminotransferase during long-term treatment with acetaminophen in osteoarthritis clinical trials Edwin K. Kuffner, Anthony R. Temple, Kimberly Cooper, Current Medical Research and Opinion	2006	61
Episodic Nature of Symptoms in Irritable Bowel Syndrome Olafur S. Palsson, Jeffrey S. Baggish, William E. Whitehead The American Journal of Gastroenterology	2014	45
Higher Doses of Subcutaneous IgG Reduce Resource Utilization in Patients with Primary Immunodeficiency Élie Haddad, Melvin Berger, Edward C. Y. Wang, Journal of Clinical Immunology	2011	28
Patients with primary immunodeficiency receiving subcutaneous immune globulin Hizentra maintain health-related quality of life and treatment satisfaction in a multicentre extension study of efficacy, tolerability and safety Christopher A. Jones, Mikhail Rojavin, Jeffrey S. Baggish Journal of Pharmaceutical Health Services Research Quality Of LifeMulticentre Extension StudyImmunodeficienciesImmunologyPharmacotherapy	2011	14

Page 1